Budesonide/formoterol pressurized metered-dose inhaler: a guide to its use in chronic obstructive pulmonary disease

被引：0
|
作者：
机构：
来源：
Drugs & Therapy Perspectives | 2010年 / 26卷 / 11期
关键词：
D O I：
10.2165/11204250-000000000-00000
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：6 / 9
页数：3
相关论文
共 50 条
  • [41] Efficacy and Safety of Budesonide and Formoterol in One Pressurized Metered-Dose Inhaler in Patients with Moderate to Very Severe Chronic Obstructive Pulmonary DiseaseResults of a 6-Month Randomized Clinical Trial
    Donald P. Tashkin
    Stephen I. Rennard
    Paula Martin
    Sulabha Ramachandran
    Ubaldo J. Martin
    Philip E. Silkoff
    Mitchell Goldman
    Drugs, 2008, 68 : 1975 - 2000
  • [42] Efficacy and Tolerability of Budesonide/Formoterol in One Hydrofluoroalkane Pressurized Metered-Dose Inhaler in Patients with Chronic Obstructive Pulmonary DiseaseResults from a 1-Year Randomized Controlled Clinical Trial
    Stephen I. Rennard
    Donald P. Tashkin
    Jennifer McElhattan
    Mitchell Goldman
    Sulabha Ramachandran
    Ubaldo J. Martin
    Philip E. Silkoff
    Drugs, 2009, 69 : 549 - 565
  • [43] Single inhaler budesonide/formoterol in exacerbations of chronic obstructive pulmonary disease
    Cazzola, M
    PULMONARY PHARMACOLOGY & THERAPEUTICS, 2006, 19 (02) : 79 - 89
  • [44] Efficacy and safety of budesonide administered by pressurized metered-dose inhaler in children with asthma
    Meltzer, Eli O.
    Pearlman, David S.
    Eckerwall, Goran
    Uryniak, Tom
    DePietro, Michael
    Lampl, Kathy
    ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2015, 115 (06) : 516 - 522
  • [45] Effect Of Budesonide/Formoterol Pressurized Metered-Dose Inhaler On Predefined Asthma Events In 4 Different Patient Populations With Asthma
    Murphy, K. R.
    Uryniak, T.
    Martin, U. J.
    Zangrilli, J.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2011, 183
  • [46] Safety of budesonide and formoterol administered via one pressurized metered-dose inhaler (budesonide/formoterol pMDI) in patients (≥12 years) with moderate to severe persistent asthma
    Rosenwasser, L. J.
    Noonan, M. J.
    Martin, P.
    O'Dowd, L.
    O'Brien, C. D.
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2007, 119 (01) : S5 - S5
  • [47] Budesonide/Glycopyrrolate/Formoterol Fumarate Co-suspension Metered Dose Inhaler: A Triple Therapy for the Treatment of Chronic Obstructive Pulmonary Disease
    Nigro, Stefanie C.
    Sobieraj, Diana M.
    ANNALS OF PHARMACOTHERAPY, 2022, 56 (05) : 582 - 591
  • [48] EFFICACY OF BUDESONIDE/FORMOTEROL PRESSURIZED METERED-DOSE INHALER VERSUS BUDESONIDE ALONE IN CHILDREN (6-<12 YEARS) WITH ASTHMA
    Pearlman, D.
    Eckerwall, G.
    McLaren, J.
    Lamarca, R.
    Puu, M.
    Jorup, C.
    Sandin, K.
    Lanz, M.
    ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2016, 117 (05) : S8 - S8
  • [49] Efficacy of Budesonide/Formoterol Pressurized Metered-Dose Inhaler in Patients With Moderate to Severe Asthma With and Without Fixed Airflow Obstruction
    Tashkin, D. P.
    Chipps, B. E.
    Uryniak, T.
    Zhao, S.
    Zangrilli, J. G.
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2012, 129 (02) : AB76 - AB76
  • [50] Comparable long-term safety and efficacy of a novel budesonide/formoterol pressurized metered-dose inhaler versus budesonide/formoterol Turbuhaler® in adolescents and adults with asthma
    Morice, Alyn H.
    Hochmuth, Ludek
    Ekelund, Jan
    Thoren, Anders
    Puterman, Allan S.
    PULMONARY PHARMACOLOGY & THERAPEUTICS, 2008, 21 (01) : 32 - 39
12345